GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Cash Flow for Lease Financing

BCAL Diagnostics (ASX:BDX) Cash Flow for Lease Financing : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Cash Flow for Lease Financing?

BCAL Diagnostics's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was A$0.00 Mil. BCAL Diagnostics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), BCAL Diagnostics's Cash Flow for Lease Financing remained the same in Dec. 2023 (A$0.00 Mil).


BCAL Diagnostics Cash Flow for Lease Financing Historical Data

The historical data trend for BCAL Diagnostics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Cash Flow for Lease Financing Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Cash Flow for Lease Financing
- -

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial - - - - -

BCAL Diagnostics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BCAL Diagnostics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


BCAL Diagnostics (ASX:BDX) Business Description

Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.